About Allander Biotechnologies
Allander Biotechnologies is a company based in Aurora (United States) founded in 2014 by Xiao Jing Wang.. Allander Biotechnologies has raised $1 million across 6 funding rounds from investors including HHS. Allander Biotechnologies offers products and services including Proprietary Biologics. Allander Biotechnologies operates in a competitive market with competitors including Aclaris Therapeutics, Avidity Biosciences, Escient Pharmaceuticals, Nimbus Therapeutics and Univercells, among others.
- Headquarter Aurora, United States
- Founders Xiao Jing Wang
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1 M (USD)
in 6 rounds
-
Latest Funding Round
$1 M (USD), Seed
Oct 02, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allander Biotechnologies
Allander Biotechnologies offers a comprehensive portfolio of products and services, including Proprietary Biologics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biologics for treating tissue regeneration and inflammation defects.
Funding Insights of Allander Biotechnologies
Allander Biotechnologies has successfully raised a total of $1M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $1.0M
-
First Round
First Round
(01 Sep 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Seed - Allander Biotechnologies | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Allander Biotechnologies | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - Allander Biotechnologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Allander Biotechnologies
Allander Biotechnologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Allander Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Allander Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Allander Biotechnologies Comparisons
Competitors of Allander Biotechnologies
Allander Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, Avidity Biosciences, Escient Pharmaceuticals, Nimbus Therapeutics and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Allander Biotechnologies
Frequently Asked Questions about Allander Biotechnologies
When was Allander Biotechnologies founded?
Allander Biotechnologies was founded in 2014.
Where is Allander Biotechnologies located?
Allander Biotechnologies is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Is Allander Biotechnologies a funded company?
Allander Biotechnologies is a funded company, having raised a total of $1M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.68M, raised on Sep 01, 2014.
What does Allander Biotechnologies do?
Allander Biotechnologies was founded in 2014 and is headquartered in Aurora, United States. Operations focus on the biotechnology sector, where proprietary cell-penetrating biologics are developed for local or topical application. These products target tissue regeneration and anti-inflammation for ulcer and wound management. The company is led by founder and president Xiao Jing Wang, with activities centered on advancing regenerative therapies.
Who are the top competitors of Allander Biotechnologies?
Allander Biotechnologies's top competitors include Sutro Biopharma, Escient Pharmaceuticals and Nimbus Therapeutics.
What products or services does Allander Biotechnologies offer?
Allander Biotechnologies offers Proprietary Biologics.
Who are Allander Biotechnologies's investors?
Allander Biotechnologies has 1 investor. Key investors include HHS.